Venkatesh Sundararajan

Has grant

Associate Professor

West Virginia University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Venkatesh Sundararajan is an Associate Professor at West Virginia University, USA. His research areas encompass mitochondrial dysfunction, cardiac health, and the molecular mechanisms involved in diabetic cardiomyopathy. Recent publications highlight his work on therapeutic targets for cardiac diseases and the role of host mitochondria in COVID-19 pathology.

Recent Grants

Grant: Close

Regulation of mitochondrial proteostasis by LonP1 in cardiac function and protection

Open Date: 2021-06-01

Close Date: 2024-05-31

Grant: Close

Mitochondrial protein quality control in cardioprotection

Open Date: 2020-07-01

Close Date: 2023-06-30

Grant: Close

Mitochondrial protein quality control in cardioprotection

Open Date: 2020-07-01

Close Date: 2023-06-01

Articles (12)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Sanchita Kashyap

Weill Cornell Medicine

UNITED STATES

View details

Tadashi Honda

Research Professor

Stony Brook University

UNITED STATES

View details

Michinari Nakamura

Rutgers New Jersey Medical School

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Venkatesh Sundararajan

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (12)

Systemic Lonp1 Haploinsufficiency Mitigates Cardiac Mitochondrial Dysfunction Induced by Cardiomyocyte-Specific Lonp1 Haploinsufficiency via Potential Inter-Organ Crosstalk

Aging triggers mitochondrial, endoplasmic reticulum, and metabolic stress responses in the heart

Correction to: Mitochondrial complex-1 as a therapeutic target for cardiac diseases

Mitochondrial complex-1 as a therapeutic target for cardiac diseases

Effect of hyperglycemia on tbx5a and nppa gene expression and its correlation to structural and functional changes in developing zebrafish heart

A commentary on “PI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and Omicron”

Inhibition of mitochondrial LonP1 protease by allosteric blockade of ATP binding and hydrolysis via CDDO and its derivatives

Editorial: Understanding Molecular Mechanisms in Diabetic Cardiomyopathy (DCM)

Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?

Nampt Potentiates Antioxidant Defense in Diabetic Cardiomyopathy

Proteomic analysis of mitochondrial biogenesis in cardiomyocytes differentiated from human induced pluripotent stem cells.

Cell stress management by the mitochondrial LonP1 protease – Insights into mitigating developmental, oncogenic and cardiac stress

Collaborators (3)

Sanchita Kashyap

Tadashi Honda

Michinari Nakamura

Make your next move.